Conditionnement : 30ml
Aurion has developed BSA-c™ , a unique incubation buffer additive with an unparalleled ability to effectively prevent charge based background. BSA-c™ is prepared by acetylation of bovine serum albumin (BSA). Polycationic sites in the specimen interact readily with negatively charged acetylated BSA molecules. This significantly reduces the risk that such sites might bind negatively-charged immunoreagents and immunogold conjugates and thus reduces the risk of background.
Introduction Procedures to eliminate background comprise three main steps:
AURION BSA-c™ is a particularly effective reagent for this purpose.
AURION BSA-c™ is a buffer additive that helps prevent immunodetection reagents (i.e. primary antibodies and secondary reagents) from binding nonspecifically to charged moieties within the specimen. Thus, it suppresses background competitively with little or no effect on the specific reaction. Its successful application is not limited to immunogold detections but it is equally efficient in fluorescent and enzyme-based detection systems. AURION BSA-c™ concentrations as low as 0.01-0.1% inhibit binding of gold conjugate to polycationic poly-l-lysine coated grids almost completely (>99%).
The surface properties of the specimen can be simplified by division into four compartments: – negatively charged (polyanions, proteins, especially after aldehyde fixation, lipids); 0 neutral; + positively charged (histone proteins, polycations) and H hydrophobic (lipids, fat droplets, resins). After an appropriate blocking step these areas are covered with blocking compounds.
In low ionic strength media negatively charged antibodies and gold conjugates are repulsed by negatively charged specimen areas which frequently may contain the antigens to be detected. Background does not likely occur in such areas. The positively charged areas attract antibodies and gold conjugates potentially leading to background. In a moderate ionic strength incubation solution, repulsion and attraction are diminished due to the presence of ions. The negatively charged BSA-c™ competes with the negatively charged antibodies and gold reagents for non-specific binding to the positively charged specimen compounds, thus reducing background to the greatest possible extent without interfering with antigen detection.
Product Description AURION BSA-c™ concentrated solution contains acetylated bovine serum albumin as the functional constituent. By acetylation of amines on basic amino acids these groups are no longer as easily protonated and the isoelectric point of such molecules is lowered and hydrophobicity is increased. BSA-c™ is a 10% solution of acetylated BSA at slightly alkaline pH with Kathon CG as preservative. The bovine serum albumin that Aurion uses to prepare BSA-c™ is obtained from healthy livestock. The charge dependent background inhibition capacity of the BSA-c™ in each lot is determined using a dot-spot test system with polycationic compounds. Two package volumes are available which yield 1.5 – 3 and 5 -10 litres of incubation buffer respectively
Application Instructions Detailed information is provided in the package inserts.
Recommended Incubation Solution:
PBS, (10 mM Phosphate buffer, 150 mM NaCl) 0.1-0.2 % AURION BSA-c™ 15 mM NaN3 pH 7.4
After addition of the BSA-c™ concentrate the pH should be checked and adjusted to 7.4 if necessary. This Incubation Solution is used throughout the whole set of reactions and washing steps (i.e. from immediately after the blocking step, through the primary antibody incubations, in-between washing steps, secondary incubation and the final washing steps).
Note on background prevention: A special AURION Newsletter on background is available in the Sharing our Knowledge section of this website.
Storage AURION BSA-c™ concentrate has a guaranteed shelf life of 18 months from the date of quality control analysis. The products should be stored at 4-8°C. Freezing is not recommended.
